rs1472949

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_145207.3(AFG2A):​c.2079+6G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.939 in 1,613,580 control chromosomes in the GnomAD database, including 712,732 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.89 ( 61328 hom., cov: 32)
Exomes 𝑓: 0.94 ( 651404 hom. )

Consequence

AFG2A
NM_145207.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00001721
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.739

Publications

10 publications found
Variant links:
Genes affected
AFG2A (HGNC:18119): (AFG2 AAA ATPase homolog A) This gene encodes a member of the ATPase associated with diverse activities family, whose members are defined by a highly conserved ATPase domain. Members of this family participate in diverse cellular processes that include membrane fusion, DNA replication, microtubule severing, and protein degradation. The protein encoded by this gene has a putative mitochondrial targeting sequence and has been proposed to function in maintenance of mitochondrial function and integrity during mouse spermatogenesis. Allelic variants in this gene have been associated with epilepsy, hearing loss, and cognitive disability syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
AFG2A Gene-Disease associations (from GenCC):
  • microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 4-123028401-G-A is Benign according to our data. Variant chr4-123028401-G-A is described in ClinVar as Benign. ClinVar VariationId is 203522.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.945 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AFG2ANM_145207.3 linkc.2079+6G>A splice_region_variant, intron_variant Intron 11 of 15 ENST00000274008.5 NP_660208.2 Q8NB90-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AFG2AENST00000274008.5 linkc.2079+6G>A splice_region_variant, intron_variant Intron 11 of 15 1 NM_145207.3 ENSP00000274008.3 Q8NB90-1
AFG2AENST00000422835.2 linkn.2121+6G>A splice_region_variant, intron_variant Intron 11 of 14 1
AFG2AENST00000675612.1 linkc.2148+6G>A splice_region_variant, intron_variant Intron 12 of 16 ENSP00000502453.1 A0A6Q8PGU6

Frequencies

GnomAD3 genomes
AF:
0.895
AC:
136065
AN:
152092
Hom.:
61286
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.788
Gnomad AMI
AF:
0.998
Gnomad AMR
AF:
0.871
Gnomad ASJ
AF:
0.920
Gnomad EAS
AF:
0.959
Gnomad SAS
AF:
0.912
Gnomad FIN
AF:
0.929
Gnomad MID
AF:
0.810
Gnomad NFE
AF:
0.951
Gnomad OTH
AF:
0.887
GnomAD2 exomes
AF:
0.917
AC:
230262
AN:
251028
AF XY:
0.922
show subpopulations
Gnomad AFR exome
AF:
0.790
Gnomad AMR exome
AF:
0.850
Gnomad ASJ exome
AF:
0.918
Gnomad EAS exome
AF:
0.963
Gnomad FIN exome
AF:
0.927
Gnomad NFE exome
AF:
0.948
Gnomad OTH exome
AF:
0.915
GnomAD4 exome
AF:
0.943
AC:
1378684
AN:
1461370
Hom.:
651404
Cov.:
38
AF XY:
0.943
AC XY:
685306
AN XY:
727022
show subpopulations
African (AFR)
AF:
0.783
AC:
26200
AN:
33458
American (AMR)
AF:
0.851
AC:
38065
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.916
AC:
23921
AN:
26128
East Asian (EAS)
AF:
0.958
AC:
38024
AN:
39684
South Asian (SAS)
AF:
0.911
AC:
78576
AN:
86244
European-Finnish (FIN)
AF:
0.930
AC:
49689
AN:
53414
Middle Eastern (MID)
AF:
0.824
AC:
4743
AN:
5758
European-Non Finnish (NFE)
AF:
0.956
AC:
1063089
AN:
1111588
Other (OTH)
AF:
0.934
AC:
56377
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
3692
7384
11077
14769
18461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21594
43188
64782
86376
107970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.895
AC:
136167
AN:
152210
Hom.:
61328
Cov.:
32
AF XY:
0.894
AC XY:
66535
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.788
AC:
32706
AN:
41512
American (AMR)
AF:
0.871
AC:
13318
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.920
AC:
3195
AN:
3472
East Asian (EAS)
AF:
0.959
AC:
4975
AN:
5186
South Asian (SAS)
AF:
0.912
AC:
4400
AN:
4824
European-Finnish (FIN)
AF:
0.929
AC:
9839
AN:
10596
Middle Eastern (MID)
AF:
0.816
AC:
240
AN:
294
European-Non Finnish (NFE)
AF:
0.951
AC:
64714
AN:
68022
Other (OTH)
AF:
0.889
AC:
1872
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
692
1384
2077
2769
3461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
902
1804
2706
3608
4510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.932
Hom.:
275772
Bravo
AF:
0.884
Asia WGS
AF:
0.937
AC:
3259
AN:
3478
EpiCase
AF:
0.950
EpiControl
AF:
0.943

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.2
DANN
Benign
0.54
PhyloP100
-0.74
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000017
dbscSNV1_RF
Benign
0.010
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1472949; hg19: chr4-123949556; API